Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neuroimmunol. 2005 Aug;165(1-2):186-91.

Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.

Author information

1
Department of Neurology, University Hospital Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. gold@uke.uni-hamburg.de

Abstract

Clinical studies have shown that groups of multiple sclerosis (MS) patients exhibit a chronically activated hypothalamo-pituitary-adrenal (HPA) axis. However, the association of HPA axis activity and disease progression in MS is unknown. In this longitudinal study over a 3-year follow-up period, we report that patients who exhibited stronger HPA reactivity at baseline were significantly more likely to experience progression as measured by the Expanded Disability Status Scale (EDSS) during the follow-up period. Furthermore, HPA axis activity correlated with progression ratings and cognitive impairment three years later. Tests of HPA axis activity may be useful biomarkers for disease progression in MS.

PMID:
15935481
DOI:
10.1016/j.jneuroim.2005.04.014
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center